Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 251

    1.

    Combined therapy with azathioprine, prednisolone, and ursodiol in patients with primary sclerosing cholangitis. A case series.

    Schramm C, Schirmacher P, Helmreich-Becker I, Gerken G, zum Büschenfelde KH, Lohse AW.

    Ann Intern Med. 1999 Dec 21;131(12):943-6.PMID: 10610645 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    A prospective, randomized-controlled pilot study of ursodeoxycholic acid combined with mycophenolate mofetil in the treatment of primary sclerosing cholangitis.

    Sterling RK, Salvatori JJ, Luketic VA, Sanyal AJ, Fulcher AS, Stravitz RT, Contos MJ, Mills AS, Shiffman ML.

    Aliment Pharmacol Ther. 2004 Nov 1;20(9):943-9.PMID: 15521841 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Medical treatment of primary biliary cirrhosis and primary sclerosing cholangitis.

    Holtmeier J, Leuschner U.

    Digestion. 2001;64(3):137-50. Review.PMID: 11786661 [PubMed - indexed for MEDLINE]Related articles

    4.

    Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis.

    Tung BY, Emond MJ, Haggitt RC, Bronner MP, Kimmey MB, Kowdley KV, Brentnall TA.

    Ann Intern Med. 2001 Jan 16;134(2):89-95.PMID: 11177311 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    A preliminary trial of high-dose ursodeoxycholic acid in primary sclerosing cholangitis.

    Mitchell SA, Bansi DS, Hunt N, Von Bergmann K, Fleming KA, Chapman RW.

    Gastroenterology. 2001 Oct;121(4):900-7.PMID: 11606503 [PubMed - indexed for MEDLINE]Related articles

    6.
    7.

    Ursodeoxycholic acid therapy for primary sclerosing cholangitis: results of a 2-year randomized controlled trial to evaluate single versus multiple daily doses.

    van Hoogstraten HJ, Wolfhagen FH, van de Meeberg PC, Kuiper H, Nix GA, Becx MC, Hoek AC, van Houte DP, Rijk MC, Salemans JM, Scherpenisse J, Schrijver M, Smit AM, Spoelstra P, Stadhouders PH, Tan TG, Hop WC, ten Kate FJ, vanBerge-Henegouwen GP, Schalm SW, van Buuren HR.

    J Hepatol. 1998 Sep;29(3):417-23.PMID: 9764988 [PubMed - indexed for MEDLINE]Related articles

    8.

    Ursodeoxycholic acid and methotrexate for primary sclerosing cholangitis: a pilot study.

    Lindor KD, Jorgensen RA, Anderson ML, Gores GJ, Hofmann AF, LaRusso NF.

    Am J Gastroenterol. 1996 Mar;91(3):511-5.PMID: 8633500 [PubMed - indexed for MEDLINE]Related articles

    9.

    Metronidazole and ursodeoxycholic acid for primary sclerosing cholangitis: a randomized placebo-controlled trial.

    Färkkilä M, Karvonen AL, Nurmi H, Nuutinen H, Taavitsainen M, Pikkarainen P, Kärkkäinen P.

    Hepatology. 2004 Dec;40(6):1379-86.PMID: 15565569 [PubMed - indexed for MEDLINE]Related articles

    10.

    Three paediatric cases of primary sclerosing cholangitis treated with ursodeoxycholic acid and sulphasalazine.

    Kozaiwa K, Tajiri H, Sawada A, Tada K, Etani Y, Miki K, Okada S.

    J Gastroenterol Hepatol. 1998 Aug;13(8):825-9.PMID: 9736177 [PubMed - indexed for MEDLINE]Related articles

    11.

    Paradoxical progression of biliary strictures against recovery of biochemical parameters under ursodeoxycholic acid treatment in a case of primary sclerosing cholangitis with ulcerative colitis.

    Komatsu K, Shimosegawa T, Kikuchi S, Uchi M, Maruhama Y, Kisara N, Ueno Y, Toyota T.

    Intern Med. 2000 Dec;39(12):1049-53.PMID: 11197788 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Impact of inflammatory bowel disease and ursodeoxycholic acid therapy on small-duct primary sclerosing cholangitis.

    Charatcharoenwitthaya P, Angulo P, Enders FB, Lindor KD.

    Hepatology. 2008 Jan;47(1):133-42.PMID: 17992695 [PubMed - indexed for MEDLINE]Related articles

    13.

    [Treatment of cholestatic liver diseases]

    Gatzen M, Pausch J.

    Med Klin (Munich). 2002 Mar 15;97(3):152-9. Review. German. PMID: 11957790 [PubMed - indexed for MEDLINE]Related articles

    14.

    Does ursodeoxycholic acid mediate immunomodulatory and anti-inflammatory effects in patients with primary sclerosing cholangitis?

    van Milligen de Wit AW, Kuiper H, Camoglio L, van Bracht J, Jones EA, Tytgat GN, van Deventer SJ.

    Eur J Gastroenterol Hepatol. 1999 Feb;11(2):129-36.PMID: 10102223 [PubMed - indexed for MEDLINE]Related articles

    15.

    Ursodeoxycholic acid does not improve the clinical course of primary sclerosing cholangitis over a 2-year period.

    De Maria N, Colantoni A, Rosenbloom E, Van Thiel DH.

    Hepatogastroenterology. 1996 Nov-Dec;43(12):1472-9.PMID: 8975951 [PubMed - indexed for MEDLINE]Related articles

    16.

    Overlap syndrome of primary biliary cirrhosis and autoimmune hepatitis: a retrospective study of 115 cases of autoimmune liver disease.

    Heurgué A, Vitry F, Diebold MD, Yaziji N, Bernard-Chabert B, Pennaforte JL, Picot R, Louvet H, Frémond L, Geoffroy P, Schmit JL, Cadiot G, Thiéfin G.

    Gastroenterol Clin Biol. 2007 Jan;31(1):17-25.PMID: 17273128 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    High-dose ursodeoxycholic acid for the treatment of primary sclerosing cholangitis.

    Lindor KD, Kowdley KV, Luketic VA, Harrison ME, McCashland T, Befeler AS, Harnois D, Jorgensen R, Petz J, Keach J, Mooney J, Sargeant C, Braaten J, Bernard T, King D, Miceli E, Schmoll J, Hoskin T, Thapa P, Enders F.

    Hepatology. 2009 Sep;50(3):808-14.PMID: 19585548 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Autoimmune hepatitis 2 years after the diagnosis of primary sclerosing cholangitis: an unusual overlap syndrome in a 17-year-old adolescent.

    Mueller T, Bianchi L, Menges M.

    Eur J Gastroenterol Hepatol. 2008 Mar;20(3):232-6.PMID: 18301306 [PubMed - indexed for MEDLINE]Related articles

    19.

    Primary sclerosing cholangitis in a child.

    Lin WT, Lin SJ, Ni YH, Chen HL, Wang HP, Chu JS, Chang MH.

    J Formos Med Assoc. 1999 Mar;98(3):209-13.PMID: 10365542 [PubMed - indexed for MEDLINE]Related articles

    20.

    Ursodeoxycholic acid for treatment of primary sclerosing cholangitis: a placebo-controlled trial.

    Beuers U, Spengler U, Kruis W, Aydemir U, Wiebecke B, Heldwein W, Weinzierl M, Pape GR, Sauerbruch T, Paumgartner G.

    Hepatology. 1992 Sep;16(3):707-14.PMID: 1505913 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data